Cardiovascular Systems ROA 2006-2019 | CSII

Current and historical return on assets (ROA) values for Cardiovascular Systems (CSII) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Cardiovascular Systems ROA for the three months ending September 30, 2019 was -1.47%.
Cardiovascular Systems ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2019-09-30 $-0.00B $0.22B -1.87%
2019-06-30 $-0.00B $0.22B -0.48%
2019-03-31 $0.00B $0.21B 0.97%
2018-12-31 $0.00B $0.21B 0.50%
2018-09-30 $0.00B $0.20B 0.51%
2018-06-30 $0.00B $0.20B 1.03%
2018-03-31 $-0.00B $0.20B -0.52%
2017-12-31 $-0.00B $0.19B -1.58%
2017-09-30 $-0.00B $0.19B -1.10%
2017-06-30 $-0.00B $0.19B -1.18%
2017-03-31 $-0.01B $0.19B -5.11%
2016-12-31 $-0.03B $0.16B -19.86%
2016-09-30 $-0.05B $0.14B -31.25%
2016-06-30 $-0.06B $0.14B -37.33%
2016-03-31 $-0.06B $0.15B -38.16%
2015-12-31 $-0.05B $0.15B -28.96%
2015-09-30 $-0.04B $0.16B -21.93%
2015-06-30 $-0.03B $0.17B -18.51%
2015-03-31 $-0.03B $0.18B -18.78%
2014-12-31 $-0.03B $0.18B -18.08%
2014-09-30 $-0.04B $0.18B -20.27%
2014-06-30 $-0.04B $0.18B -22.40%
2014-03-31 $-0.03B $0.19B -23.66%
2013-12-31 $-0.03B $0.18B -24.58%
2013-09-30 $-0.03B $0.10B -29.89%
2013-06-30 $-0.02B $0.10B -30.67%
2013-03-31 $-0.02B $0.10B -31.54%
2012-12-31 $-0.02B $0.06B -34.78%
2012-09-30 $-0.02B $0.06B -32.00%
2012-06-30 $-0.02B $0.06B -31.92%
2012-03-31 $-0.01B $0.05B -28.43%
2011-12-31 $-0.01B $0.05B -25.13%
2011-09-30 $-0.01B $0.05B -21.74%
2011-06-30 $-0.01B $0.05B -22.47%
2011-03-31 $-0.01B $0.04B -27.59%
2010-12-31 $-0.02B $0.05B -35.42%
2010-09-30 $-0.02B $0.04B -41.71%
2010-06-30 $-0.02B $0.04B -40.17%
2010-03-31 $-0.03B $0.06B -38.81%
2009-12-31 $0.00B $0.06B 4.26%
2009-06-30 $0.00B $0.07B 4.00%
2009-03-31 $-0.01B $0.08B -34.38%
2008-06-30 $-0.06B $0.00B -119.15%
2008-03-31 $0.01B $0.08B 10.49%
2007-06-30 $0.03B $0.12B 31.09%
2007-03-31 $-0.02B $0.13B -25.60%
2006-09-30 $-0.04B $0.14B -48.56%
2006-06-30 $-0.04B $0.11B -98.82%
2006-03-31 $-0.04B $0.00B -256.25%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $1.844B $0.248B
Cardiovascular Systems, Inc., formerly known as Replidyne Inc., is headquartered in Saint Paul, Minnesota. It is a medical device company focusing on developing and commercializing interventional treatment systems for vascular disease. Its initial product, the Diamondback 360? Orbital Atherectomy System, is a minimally invasive catheter system for the treatment of peripheral arterial disease; and a range of plaque types, including calcified vessel lesions. The Diamondback 360? removes soft and calcified plaque in plaque-lined vessels through the orbital rotation of a diamond grit coated offset crown. The company refined its `orbital` technology to address the growing market need of providing a safer more effective atherectomy device.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $159.317B 22.01
Abbott Laboratories (ABT) United States $156.119B 28.48
Stryker (SYK) United States $78.360B 26.35
Boston Scientific (BSX) United States $60.213B 28.42
Baxter (BAX) United States $45.945B 27.86
Essilor Luxottica (ESLOY) France $34.669B 0.00
Zimmer Biomet Holdings (ZBH) United States $30.600B 19.20
Lonza Group Ag (LZAGY) Switzerland $28.331B 0.00
Terumo (TRUMY) Japan $27.798B 34.69
Coloplast (CLPBY) Denmark $27.302B 42.13
ResMed (RMD) United States $23.111B 42.63
Smith & Nephew SNATS (SNN) United Kingdom $21.536B 0.00
Sunny Optical Technology (SNPTF) China $19.930B 0.00
Insulet (PODD) United States $11.836B 563.12
Bio-Rad Laboratories (BIO) United States $11.366B 54.56
Canopy Growth (CGC) Canada $8.470B 0.00
Perrigo (PRGO) Ireland $8.100B 15.10
William Demant Holdings (WILYY) Denmark $7.896B 0.00
Hill-Rom Holdings (HRC) United States $7.790B 22.90
DiaSorin S.p.A (DSRLF) Italy $7.357B 0.00
GN STORE NORD (GNNDY) Denmark $6.158B 31.81
Haemonetics (HAE) United States $5.880B 39.73
Shandong Weigao Medical Polymer (SHWGF) China $5.020B 0.00
NuVasive (NUVA) United States $4.131B 32.53
ICU Medical (ICUI) United States $3.896B 25.40
Hutchison China MediTech (HCM) Hong Kong, SAR China $3.868B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.680B 0.00
Neogen (NEOG) United States $3.677B 61.18
Quidel (QDEL) United States $3.119B 29.60
Agios Pharmaceuticals (AGIO) United States $3.035B 0.00
National Vision Holdings (EYE) United States $2.590B 58.45
Aurora Cannabis (ACB) Canada $2.342B 0.00
AtriCure (ATRC) United States $1.453B 0.00
InMode (INMD) Israel $1.430B 0.00
TG Therapeutics (TGTX) United States $1.397B 0.00
Aphria (APHA) $1.311B 0.00
VAREX IMAGING (VREX) United States $1.218B 24.35
NanoString Technologies (NSTG) United States $1.102B 0.00
Phibro Animal Health (PAHC) United States $1.058B 19.82
PetIQ (PETQ) United States $0.884B 21.56
Eagle Pharmaceuticals (EGRX) United States $0.814B 31.18
Lantheus Holdings (LNTH) United States $0.740B 18.49
LeMaitre Vascular (LMAT) United States $0.740B 41.57
Omeros (OMER) United States $0.736B 0.00
Quanterix (QTRX) United States $0.693B 0.00
Cerus (CERS) United States $0.589B 0.00
MacroGenics (MGNX) United States $0.567B 0.00
Surmodics (SRDX) United States $0.561B 58.15
Organigram Holdings (OGI) Canada $0.531B 0.00
OraSure Technologies (OSUR) United States $0.515B 30.93
HEXO (HEXO) $0.484B 0.00
Meridian Bioscience (VIVO) United States $0.428B 14.71
Utah Medical Products (UTMD) United States $0.392B 28.40
Owens & Minor (OMI) United States $0.364B 13.47
Zynex (ZYXI) United States $0.346B 39.19
BioLife Solutions (BLFS) United States $0.325B 132.50
Bovie Medical (APYX) United States $0.286B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.272B 0.00
Female Health (VERU) United States $0.267B 0.00
Vapotherm (VAPO) United States $0.252B 0.00
United Health Products (UEEC) United States $0.233B 0.00
Viemed Healthcare (VMD) United States $0.216B 22.80
Repro-Med Systems (KRMD) United States $0.215B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.188B 0.00
Rockwell Medical (RMTI) United States $0.182B 0.00
Liberty Health Sciences (LHSIF) Canada $0.175B 0.00
InfuSystems Holdings (INFU) United States $0.171B 861.00
Cytosorbents (CTSO) United States $0.151B 0.00
Fonar (FONR) United States $0.136B 9.59
Chimerix (CMRX) United States $0.127B 0.00
MTech Acquisition (KERN) United States $0.094B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.092B 0.00
United-Guardian (UG) United States $0.090B 22.83
MRI Interventions (MRIC) United States $0.087B 0.00
Surface Oncology (SURF) United States $0.087B 0.00
Nephros (NEPH) United States $0.079B 0.00
Chembio Diagnostics (CEMI) United States $0.070B 0.00
FSD PHARMA INC (HUGE) $0.046B 0.00
ImmuCell (ICCC) United States $0.036B 0.00
Trinity Biotech (TRIB) Ireland $0.025B 0.00
GUARDION HEALTH (GHSI) United States $0.025B 0.00
Senestech (SNES) United States $0.017B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.014B 0.00
Capricor Therapeutics (CAPR) United States $0.008B 0.00
Valeritas Holdings (VLRX) United States $0.006B 0.00
Myomo (MYO) United States $0.005B 0.00
NeuroMetrix (NURO) United States $0.004B 0.00
Akers Biosciences Inc (AKER) United States $0.002B 0.00